DK0450386T3 - Fremstilling af biologisk aktive, rekombinante medlemmer af NGF/BDNF-familien af neurotrope proteiner - Google Patents
Fremstilling af biologisk aktive, rekombinante medlemmer af NGF/BDNF-familien af neurotrope proteinerInfo
- Publication number
- DK0450386T3 DK0450386T3 DK91104171T DK91104171T DK0450386T3 DK 0450386 T3 DK0450386 T3 DK 0450386T3 DK 91104171 T DK91104171 T DK 91104171T DK 91104171 T DK91104171 T DK 91104171T DK 0450386 T3 DK0450386 T3 DK 0450386T3
- Authority
- DK
- Denmark
- Prior art keywords
- ngf
- proteins
- biologically active
- bdnf
- neurotropic
- Prior art date
Links
- 108010025020 Nerve Growth Factor Proteins 0.000 title abstract 5
- 102000004219 Brain-derived neurotrophic factor Human genes 0.000 title abstract 3
- 108090000715 Brain-derived neurotrophic factor Proteins 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 230000002276 neurotropic effect Effects 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 101000739876 Homo sapiens Brain-derived neurotrophic factor Proteins 0.000 abstract 2
- 102000007072 Nerve Growth Factors Human genes 0.000 abstract 2
- 102000051542 human BDNF Human genes 0.000 abstract 2
- 229940077456 human brain-derived neurotrophic factor Drugs 0.000 abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/48—Nerve growth factor [NGF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
- C07K14/503—Fibroblast growth factor [FGF] basic FGF [bFGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/848—Escherichia
- Y10S435/849—Escherichia coli
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Animal Behavior & Ethology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50544190A | 1990-04-06 | 1990-04-06 | |
US54775090A | 1990-07-02 | 1990-07-02 | |
US07/594,126 US5235043A (en) | 1990-04-06 | 1990-10-09 | Production of biologically active, recombinant members of the ngf/bdnf family of neurotrophic proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0450386T3 true DK0450386T3 (da) | 2000-03-06 |
Family
ID=27414291
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK91104171T DK0450386T3 (da) | 1990-04-06 | 1991-03-18 | Fremstilling af biologisk aktive, rekombinante medlemmer af NGF/BDNF-familien af neurotrope proteiner |
Country Status (17)
Country | Link |
---|---|
US (1) | US5235043A (ko) |
EP (1) | EP0450386B1 (ko) |
JP (1) | JP2521851B2 (ko) |
KR (1) | KR910018545A (ko) |
AT (1) | ATE183232T1 (ko) |
AU (1) | AU651339B2 (ko) |
CA (1) | CA2038669C (ko) |
DE (1) | DE69131514T2 (ko) |
DK (1) | DK0450386T3 (ko) |
ES (1) | ES2140379T3 (ko) |
FI (1) | FI108146B (ko) |
GR (1) | GR3031632T3 (ko) |
IE (1) | IE910827A1 (ko) |
IL (1) | IL97602A (ko) |
NO (1) | NO308308B1 (ko) |
NZ (1) | NZ237544A (ko) |
TW (1) | TW206258B (ko) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5229500A (en) * | 1989-08-30 | 1993-07-20 | Regeneron Pharmaceuticals, Inc. | Brain derived neurotrophic factor |
US5180820A (en) * | 1989-08-30 | 1993-01-19 | Barde Yves Alain | Brain-derived neurotrophic factor |
US5986070A (en) * | 1990-04-06 | 1999-11-16 | Amgen Inc. | Production of biologically active NGF proteins |
US5606031A (en) * | 1990-04-06 | 1997-02-25 | Lile; Jack | Production and purification of biologically active recombinant neurotrophic protein in bacteria |
DK0547102T3 (da) * | 1990-09-05 | 1999-04-19 | Natinco Nv | Opløseliggørelse af proteiner på aktiv form |
US5530109A (en) * | 1991-04-10 | 1996-06-25 | Ludwig Institute For Cancer Research | DNA encoding glial mitogenic factors |
PT100580A (pt) * | 1991-06-12 | 1993-09-30 | Regeneron Pharma | Producao e recuperacao de neurotrofinas recombinantes |
US5389529A (en) * | 1991-06-12 | 1995-02-14 | Regeneron Pharmaceuticals, Inc. | Modified lamβ signal sequence and processes for producing recombinant neurotrophins |
DE4139000A1 (de) * | 1991-11-27 | 1993-06-03 | Boehringer Mannheim Gmbh | Verfahren zur gentechnologischen herstellung von biologisch aktivem ss-ngf |
US5488099A (en) * | 1992-03-06 | 1996-01-30 | Persson, Deceased; Hakan B. | Multifunctional chimeric neurotrophic factors |
US5328837A (en) * | 1992-05-18 | 1994-07-12 | Genentech, Inc. | Hepatocyte growth factor protease domain variants |
ATE222603T1 (de) * | 1992-05-18 | 2002-09-15 | Genentech Inc | Hepatozytwachstumfaktor variante |
US5316921A (en) * | 1992-05-18 | 1994-05-31 | Genentech, Inc. | Single-chain hepatocyte growth factor variants |
DE69330809T2 (de) * | 1992-06-08 | 2002-05-16 | Takeda Chemical Industries, Ltd. | Therapeutisches Agens für Neutropenie |
US5364645A (en) * | 1992-10-30 | 1994-11-15 | The Regents Of The University Of California | Method of controlling microorganisms by pulsed ultraviolet laser radiation |
TW248552B (ko) * | 1993-06-01 | 1995-06-01 | Onoda Yakuhin Kogyo Kk | |
ATE175677T1 (de) * | 1993-10-18 | 1999-01-15 | Regeneron Pharma | Heterodimere der wachstumsfaktoren |
US5470719A (en) * | 1994-03-18 | 1995-11-28 | Meng; Shi-Yuan | Modified OmpA signal sequence for enhanced secretion of polypeptides |
US5739307A (en) | 1995-08-28 | 1998-04-14 | Washington University | Polynucleotide encoding neurturin neurotrophic factor |
US6743628B1 (en) | 1995-08-28 | 2004-06-01 | Washington University | Method of cell culture using neurturin |
US5607711A (en) * | 1995-11-01 | 1997-03-04 | The Regents Of The University Of California | Method of controlling insects and mites with pulsed ultraviolet light |
US5859311A (en) * | 1995-11-27 | 1999-01-12 | University Of Kentucky Research Foundation | Transgenic mice which overexpress neurotrophin-3 (NT-3) and methods of use |
US6716600B1 (en) | 1996-03-14 | 2004-04-06 | Washington University | Persephin and related growth factors |
US6222022B1 (en) | 1996-03-14 | 2001-04-24 | Washington University | Persephin and related growth factors |
WO1997033911A1 (en) | 1996-03-14 | 1997-09-18 | Washington University | Persephin and related growth factors |
ES2214624T3 (es) * | 1996-06-11 | 2004-09-16 | Roche Diagnostics Gmbh | Procedimiento de activacion de proteina desnaturalizada. |
US5910435A (en) * | 1996-07-25 | 1999-06-08 | Wisconsin Alumni Research Foundation | Method of folding proteins with synthetic dithiol catalysts |
TR199901734T2 (xx) * | 1996-11-15 | 2000-01-21 | Genentech, Inc. | N�rotrofinlerin ar�t�lmas�. |
US6042579A (en) * | 1997-04-30 | 2000-03-28 | Medtronic, Inc. | Techniques for treating neurodegenerative disorders by infusion of nerve growth factors into the brain |
ES2297889T3 (es) | 1997-07-14 | 2008-05-01 | Bolder Biotechnology, Inc. | Derivados de hormona de crecimiento y proteinas relacionadas. |
WO2000042175A1 (en) * | 1999-01-14 | 2000-07-20 | Bolder Biotechnology Inc. | Methods for making proteins containing free cysteine residues |
US7495087B2 (en) | 1997-07-14 | 2009-02-24 | Bolder Biotechnology, Inc. | Cysteine muteins in the C-D loop of human interleukin-11 |
ATE257514T1 (de) * | 1998-10-09 | 2004-01-15 | Scil Proteins Gmbh | Verfahren zur gewinnung von aktivem beta-ngf |
ES2316194T3 (es) * | 1998-10-28 | 2009-04-01 | Cornell Research Foundation, Inc. | Metodos para la regulacion de la angiogenesis y la integridad vascular utilizando los ligandos bdnf, nt-3 y nt-4. |
US6329136B1 (en) | 1998-10-30 | 2001-12-11 | The Regents Of The University Of California | Method for laser inactivation of infectious agents |
US20020049303A1 (en) * | 1999-06-28 | 2002-04-25 | Tang Jordan J. N. | Catalytically active recombinant memapsin and methods of use thereof |
JP5138851B2 (ja) * | 1999-06-28 | 2013-02-06 | オクラホマ メディカル リサーチ ファウンデーション | 触媒的に活性な組換えメマプシンおよびその使用方法 |
EP1206578A2 (en) | 1999-08-11 | 2002-05-22 | Whitehead Institute For Biomedical Research | Bdnf polymorphism and association with bipolar disorder |
US7223406B2 (en) * | 2000-07-21 | 2007-05-29 | The Regents Of The University Of California | Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder |
EP1365794A2 (en) * | 2000-07-21 | 2003-12-03 | Lue, Tom | Prevention and treatment of sexual arousal disorders |
US20040121947A1 (en) * | 2000-12-28 | 2004-06-24 | Oklahoma Medical Research Foundation | Compounds which inhibit beta-secretase activity and methods of use thereof |
US20030232365A1 (en) * | 2001-02-15 | 2003-12-18 | Whitehead Institute For Biomedical Research | BDNF polymorphisms and association with bipolar disorder |
EP1233075A3 (en) * | 2001-02-15 | 2003-01-08 | Whitehead Institute For Biomedical Research | BDNF polymorphism and association with bipolar disorder |
US20060234944A1 (en) * | 2001-10-23 | 2006-10-19 | Oklahoma Medical Reseach Foundation | Beta-secretase inhibitors and methods of use |
CA2464736A1 (en) * | 2001-10-23 | 2003-05-15 | Oklahoma Medical Research Foundation | Beta-secretase inhibitors and methods of use |
US20030219696A1 (en) * | 2002-05-23 | 2003-11-27 | Moreland Gerald W. | Method and apparatus for preventing backflow in dental saliva evacuators |
JP2005305107A (ja) * | 2004-03-25 | 2005-11-04 | Sei Matsuoka | 価値的情報値の測定装置およびこれを使用した測定方法 |
JP2009505979A (ja) * | 2005-08-10 | 2009-02-12 | オクラホマ メディカル リサーチ ファンデーション | アルツハイマー病の治療に使用するためのトランケート型メマプシン2 |
WO2008002572A2 (en) * | 2006-06-27 | 2008-01-03 | The Government Of The United States Of America As Represented By The Secretary Of Health And Human Services | Method for measuring mature brain derived neurotrophic factor |
IT1394596B1 (it) * | 2008-09-30 | 2012-07-05 | Fond Parco Tecnologico Padano | Produzione di ngf in pianta. |
EP2594295A1 (en) | 2011-11-16 | 2013-05-22 | Servicio Andaluz De Salud | Nerve implants based on a compacted biomaterial containing cells |
GB201804641D0 (en) * | 2018-03-22 | 2018-05-09 | Inivata Ltd | Methods of sequencing nucleic acids and error correction of sequence reads |
IT202000032423A1 (it) | 2020-12-24 | 2022-06-24 | Univ Degli Studi Di Trieste | Metodo per la produzione di forme processate proteoliticamente di fattori trofici o fattori di crescita |
EP4413993A1 (en) * | 2023-02-10 | 2024-08-14 | Dompe' Farmaceutici S.P.A. | Method of obtaining recombinant human brain-derived neurotrophic factor |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4599197A (en) * | 1982-12-22 | 1986-07-08 | Genentech, Inc. | Purification and activity assurance of precipitated heterologous proteins |
US4511502A (en) * | 1982-12-22 | 1985-04-16 | Genentech, Inc. | Purification and activity assurance of precipitated heterologous proteins |
US4512922A (en) * | 1982-12-22 | 1985-04-23 | Genentech, Inc. | Purification and activity assurance of precipitated heterologous proteins |
US4511503A (en) * | 1982-12-22 | 1985-04-16 | Genentech, Inc. | Purification and activity assurance of precipitated heterologous proteins |
DK161152C (da) * | 1983-03-03 | 1991-11-11 | Genentech Inc | Polypeptid med egenskaber som human beta-nervevaekstfaktor og fremgangsmaade til fremstilling deraf, dna-isolat omfattende en sekvens som koder for polypeptidet, replicerbar udtrykkelsesvektor for dna-sekvensen, rekombinant vaertscelle transformeret med vektoren, farmaceutisk praeparat indeholdende polypeptidet og fremg. der omfatter anvendelsen af polypeptidet til fremst. af et farmaceutisk praeparat |
US4766205A (en) * | 1985-11-13 | 1988-08-23 | Beatrice Companies, Inc. | Method for isolation of recombinant polypeptides in biologically active forms |
US4929700A (en) * | 1987-04-16 | 1990-05-29 | Cetus Corporation | Production of purified, biologically active, bacterially produced recombinant human CSF-1 |
IT1219874B (it) * | 1988-03-18 | 1990-05-24 | Fidia Farmaceutici | Utilizzazione del fattore di crescita nervoso umano e sue composizioni farmaceutiche |
US6709837B1 (en) * | 1989-03-10 | 2004-03-23 | Takeda Chemical Industries, Inc. | Polypeptide and production thereof |
US5180820A (en) * | 1989-08-30 | 1993-01-19 | Barde Yves Alain | Brain-derived neurotrophic factor |
JPH05161493A (ja) * | 1989-08-30 | 1993-06-29 | Max Planck Ges Foerderung Wissenschaft Ev | ニューロトロフィン―3 |
IL95511A (en) * | 1989-08-30 | 2000-10-31 | Max Planck Gesellschaft | Neurotrophin-3 a novel neurotrophic factor related to nerve growth and brain derived neurotrophic factor |
US5229500A (en) * | 1989-08-30 | 1993-07-20 | Regeneron Pharmaceuticals, Inc. | Brain derived neurotrophic factor |
-
1990
- 1990-10-09 US US07/594,126 patent/US5235043A/en not_active Expired - Lifetime
-
1991
- 1991-03-12 IE IE082791A patent/IE910827A1/en not_active IP Right Cessation
- 1991-03-18 AT AT91104171T patent/ATE183232T1/de not_active IP Right Cessation
- 1991-03-18 EP EP91104171A patent/EP0450386B1/en not_active Expired - Lifetime
- 1991-03-18 ES ES91104171T patent/ES2140379T3/es not_active Expired - Lifetime
- 1991-03-18 DE DE69131514T patent/DE69131514T2/de not_active Expired - Lifetime
- 1991-03-18 DK DK91104171T patent/DK0450386T3/da active
- 1991-03-19 IL IL9760291A patent/IL97602A/xx not_active IP Right Cessation
- 1991-03-20 CA CA002038669A patent/CA2038669C/en not_active Expired - Lifetime
- 1991-03-22 NZ NZ237544A patent/NZ237544A/xx unknown
- 1991-04-03 NO NO911303A patent/NO308308B1/no not_active IP Right Cessation
- 1991-04-05 FI FI911643A patent/FI108146B/fi active
- 1991-04-05 AU AU74130/91A patent/AU651339B2/en not_active Ceased
- 1991-04-06 JP JP3073389A patent/JP2521851B2/ja not_active Expired - Lifetime
- 1991-04-06 KR KR1019910005514A patent/KR910018545A/ko not_active Application Discontinuation
- 1991-04-08 TW TW080102624A patent/TW206258B/zh not_active IP Right Cessation
-
1999
- 1999-10-21 GR GR990402673T patent/GR3031632T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
NO911303D0 (no) | 1991-04-03 |
IL97602A0 (en) | 1992-06-21 |
AU7413091A (en) | 1991-11-14 |
EP0450386A3 (en) | 1992-09-09 |
NO308308B1 (no) | 2000-08-28 |
JPH06319549A (ja) | 1994-11-22 |
FI911643A (fi) | 1991-10-07 |
IL97602A (en) | 2005-08-31 |
IE910827A1 (en) | 1991-10-09 |
DE69131514D1 (de) | 1999-09-16 |
KR910018545A (ko) | 1991-11-30 |
US5235043A (en) | 1993-08-10 |
TW206258B (ko) | 1993-05-21 |
FI108146B (fi) | 2001-11-30 |
FI911643A0 (fi) | 1991-04-05 |
EP0450386A2 (en) | 1991-10-09 |
NO911303L (no) | 1991-10-07 |
DE69131514T2 (de) | 2000-05-04 |
JP2521851B2 (ja) | 1996-08-07 |
ATE183232T1 (de) | 1999-08-15 |
EP0450386B1 (en) | 1999-08-11 |
GR3031632T3 (en) | 2000-01-31 |
CA2038669A1 (en) | 1991-10-07 |
AU651339B2 (en) | 1994-07-21 |
ES2140379T3 (es) | 2000-03-01 |
NZ237544A (en) | 1993-07-27 |
CA2038669C (en) | 2004-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0450386T3 (da) | Fremstilling af biologisk aktive, rekombinante medlemmer af NGF/BDNF-familien af neurotrope proteiner | |
ATE155525T1 (de) | Verkürzte formen den hepatozyten wachstumsfaktor (hgf) rezeptors | |
GB2269820B (en) | Recombinant pox virus encoding flaviviral structural proteins | |
ATE402957T1 (de) | Analoge des menschlichen interferon-alpha mit niedriger toxizität | |
ES2063278T3 (es) | Proteina morfogenetica de hueso. | |
ATA257190A (de) | Virales polypeptid | |
DE69203254D1 (de) | Herstellung von Crackkatalysatoren und Crackverfahren mit diesen. | |
EP0467699A3 (en) | Cyclic hiv principal neutralizing determinant peptides | |
AU5481686A (en) | Foldable framework for bed, stretcher or bridge | |
KR970702919A (ko) | 재조합형의 인간면역부전바이러스 담체 및 그 제조방법(Recombinant Human Immunodeficiency Virus Vector and Process for Producing the same) | |
DK0473503T5 (da) | Femoralt kompositimplantat med forøget halsstyrke | |
AR243237A1 (es) | Un vector de expresion recombinante que contiene una secuencia de adn que codifica el factor neurotrofico ciliar humano,un microorganismo e.coli transformado,y linea celulares transformadas. | |
ZA911834B (en) | Production of biologically active,recombinant members of the ngf/bdnf family of neurotrophic proteins | |
EP0467701A3 (en) | Cyclic hiv principal neutralizing determinant peptides | |
ATE209500T1 (de) | Ein neuartiges, antineoplastisches cytokin | |
DE69123242D1 (de) | Physiologisch aktive Peptide, ihre Verwendung und eine Methode besagte Peptide herzustellen | |
KR950010444U (ko) | 티 브이(tv)의 디지탈 컨버젼스 조정장치 | |
KR950015592U (ko) | 칼라브라운관의 퓨리티.콘버젼스 조정 마그네트 구조체 | |
KR960012903U (ko) | 프로젝션 티브이의 콘버어전스 보정회로 | |
PHUM6869Z (en) | Improved collapsible rocking chair |